1. Home
  2. TU vs EXAS Comparison

TU vs EXAS Comparison

Compare TU & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telus Corporation

TU

Telus Corporation

HOLD

Current Price

$13.63

Market Cap

21.0B

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$102.31

Market Cap

19.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TU
EXAS
Founded
1993
1995
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical Specialities
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0B
19.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TU
EXAS
Price
$13.63
$102.31
Analyst Decision
Hold
Buy
Analyst Count
3
19
Target Price
$18.17
$84.27
AVG Volume (30 Days)
4.9M
2.1M
Earning Date
02-12-2026
02-18-2026
Dividend Yield
8.86%
N/A
EPS Growth
24.25
N/A
EPS
0.56
N/A
Revenue
$14,679,551,147.00
$3,082,033,000.00
Revenue This Year
$2.94
$19.40
Revenue Next Year
$2.40
$13.51
P/E Ratio
$24.04
N/A
Revenue Growth
2.42
14.47
52 Week Low
$12.54
$38.81
52 Week High
$16.74
$102.66

Technical Indicators

Market Signals
Indicator
TU
EXAS
Relative Strength Index (RSI) 60.20 79.65
Support Level $13.27 $102.00
Resistance Level $13.64 $102.56
Average True Range (ATR) 0.19 0.33
MACD 0.06 -0.54
Stochastic Oscillator 94.72 70.31

Price Performance

Historical Comparison
TU
EXAS

About TU Telus Corporation

Telus is one of the Big Three wireless service providers in Canada, with over 10 million mobile phone subscribers nationwide constituting almost 30% of the total market. It is the incumbent local exchange carrier in the western Canadian provinces of British Columbia and Alberta, where it provides internet, television, and landline phone services. It also has a small wireline presence in eastern Quebec. Mostly because of recent acquisitions, more than 20% of Telus' sales now come from nontelecom businesses, most notably in the international business services, health, security, and agriculture industries. The firm has a 55% economic stake in Telus International.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: